Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wei
Timothy D Henry

Showing results (571-580 of 754) with videos related to

Pageof 76
Sort By:
Contemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
American Heart Journal|March 11, 2025
Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testingCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Clinical Cardiology|September 16, 2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarkerChristine Pacheco, Janet Wei, Chrisandra Shufelt, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|October 13, 2021
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAlice K Jacobs, Murtuza J Ali, Patricia J Best, et al.
Pageof 76

Showing results (571-580 of 754) with videos related to

Sort By:
Pageof 76
Contemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
American Heart Journal|March 11, 2025
Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testingCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Clinical Cardiology|September 16, 2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarkerChristine Pacheco, Janet Wei, Chrisandra Shufelt, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|October 13, 2021
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAlice K Jacobs, Murtuza J Ali, Patricia J Best, et al.
Pageof 76